Astria Therapeutics inc   (ATXS)
Other Ticker:  

Astria Therapeutics Inc's Customers Performance


ATXS's Source of Revenues

List of ATXS Customers

for the same period Astria Therapeutics Inc

List of ATXS Customers

Astria Therapeutics Inc's Comment on Sales, Marketing and Customers

  News about Astria Therapeutics inc Contracts

Astria Therapeutics' Strong Financial Results and Promising Outlook for HAE Treatment

Abstract:This article highlights the financial results and corporate updates of Astria Therapeutics, a leading biopharmaceutical company focusing on treatments for allergic and immunological diseases. The company reported robust financial performance for the fourth quarter and full year of 2023 and emphasized its belief in the potential of STAR-0215 as the preferred preventative therapy for Hereditary Angioedema (HAE). The successful outcomes further solidify Astria Therapeutics' position in the market, inspiring hope for improved patient outcomes and quality of life.Astria Therapeutics, Inc., a biopharmaceutical company dedicated to advancing treatments for allergic and immunological diseases, recently rele...

ATXS's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

Astria Therapeutics inc 293.67 0.00 -72.89 10
SUBTOTAL 0.00 0.00 0.00 -


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com